Intuitive's sales and profits exceeded expectations, but a warning about Trump's import tax proposal may have worried ...
RevMedica announced that the FDA accepted its Endo stapling platform into its Safer Technologies Program (STeP).
A federal judge rejected Intuitive's request to end an antitrust trial. The case involves third-party servicing of robotic surgery tools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback